Good News | Tongee Medical's Gastric Bypass Stent System Obtains Medical Device Registration Certificate in Colombia, Expanding Its Global Health Footprint

Recently, the Gastric Bypass Stent System independently developed by Tongee Medical successfully obtained medical device marketing approval in Colombia, offering a novel, super minimally invasive, and reversible interventional treatment option for patients with metabolic diseases in the country. This not only signifies another key expansion of Tongee Medical's business footprint in Latin America following Ecuador, but also demonstrates that the innovative product strength and clinical value of Tongee Medical have gained official recognition from another important nation.

As a key participant in the Belt and Road Initiative, Colombia's approval is not only a breakthrough in market access but also a solid step for the company in deeply integrating into the medical and health systems of Belt and Road partner countries. This "year-end gift" is the best reward for the team's commitment to innovation and internationalization.

As an innovative medical device enterprise incubated in China, Tongee Medical has always been committed to bringing its self-developed advanced treatment solutions to the world. Colombia, as one of the important economies in South America, faces an increasingly heavy burden of metabolic diseases. Data shows that the adult obesity rate in the country is nearly 60%, and the prevalence of diabetes continues to rise. The introduction of the Gastric Bypass Stent System not only enables more local patients to benefit from this advanced, originally Chinese treatment solution but also provides the local healthcare system with a new tool to address the challenge of obesity.

The successful approval in Colombia is the result of the company's efforts to align with international standards and overcome market barriers, leveraging its robust product quality and scientific clinical data. This fully demonstrates the potential and responsibility of Chinese enterprises to participate in global health governance through innovative technologies.

In the future, Tongee Medical will continue to deepen cooperation with countries along the Belt and Road, accelerate the construction of a metabolic disease management ecosystem centered on the Gastric Bypass Stent System, and provide global patients with an integrated "hardware + software + services" solution. With solid steps, Tongee Medical is proving to the world that Chinese medical innovations can not only address local health challenges, but also contribute wisdom and strength to global public health efforts!